Skip to main content
. 2005 Feb;58(2):178–184. doi: 10.1136/jcp.2004.019224

Table 2.

 Alterations of the mononuclear inflammatory cells in the BALF, blood, and the skin of patients with SSc and healthy controls

SSc (n = 19) lSSc (n = 10) dSSc (n = 9) HC (n = 6) p Value
BALF
    Total 238 (49.8) 214 (32.8) 260 (53.7) 157.5 (59.40 <0.05
    Monocytes 80.7 (3.2) 81.2 (4.5) 79.6 (8.8) 90.2 (1.5) NS
    Lymphocytes 13.5 (1.3) 14.2 (4.1) 12.9 (5.8) 6.5 (2.1) <0.05
    Neutrophils 4.3 (0.6) 4.1 (1.2) 4.7 (2.0) 2.2 (0.3) <0.05
    Eosinophils 1.5 (1.6) 1.1 (0.6) 1.1 (0.9) 1.1 (0.6) NS
Blood
    Total 8.3 (3.1) 8.3 (3.8) 8.3 (2.5) 6.1 (1.01) NS
    Monocytes 5.0 (3.6) 4.1 (2.2) 5.9 (4.6) 4.7 (1.2) NS
    Lymphocytes 37.3 (15.8) 42.0 (14.5) 32.1 (16.4) 40.8 (5.8) NS
    Neutrophils 52.0 (18.5) 46.4 (16.8) 57.6 (19.6) 46.5 (7.7) NS
    Eosinophils 5.8 (3.8) 7.4 (3.4) 4.1 (3.8) 1.0 (1.0) <0.05
Skin
    Total 3.9 (3.6) 3.6 (3.4) 4.3 (4.0) 2.1 (1.7) NS
    Histiocytes 10.1 (3.9) 10.9 (4.4) 10.7 (4.2) 2.0 (0.3) <0.05
    Lymphocytes 4.2 (1.8) 2.9 (2.2) 5.8 (1.7) 7.5 (1.8) <0.05
    Neutrophils 0.3 (0.3) 0.3 (0.3) 0.3 (0.3) 0.0 (0.0) <0.05
    Eosinophils 0.3 (0.2) 0.3 (0.3) 0.3 (0.3) 0.0 (0.0) <0.05

Values are mean (SD).

The p values are for patients with SSc compared with HCs.

BALF, bronchoalveolar lavage fluid; dSSc, diffuse systemic sclerosis; HC, healthy controls; lSSc, limited systemic sclerosis; SSc, systemic sclerosis.